ATRA News

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

ATRA EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 Ready to Announce with Confidence?

Lost Money on Atara Biotherapeutics, Inc. (ATRA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Pomerantz LLP Pursues Shareholder Class Action Against Atara Biotherapeutics, Inc. – ATRA

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

ATRA INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Atara Biotherapeutics, Inc. Investors

Pomerantz Law Firm Announces The Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA

DEADLINE ALERT for ATRA, COTY, SMCI, IBRX: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm